Corneal Collagen Crosslinking for Keratoconus and Ectasia Using Riboflavin/Dextran or Riboflavin/Methylcellulose
Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
This study is being conducted to evaluate the safety and efficacy of isotonic riboflavin for
corneal collagen crosslinking for keratoconus and corneal ectasia. will determine the safety
and efficacy of corneal collagen crosslinking (CXL) performed with two different riboflavin
formulations for reducing corneal curvature.